Arresting progressive atherosclerosis by immunization with an anti-glycosaminoglycan monoclonal antibody in apolipoprotein E-deficient mice
- 1 December 2015
- journal article
- Published by Elsevier in Free Radical Biology and Medicine
- Vol. 89, 557-566
Abstract
No abstract availableKeywords
Funding Information
- Center of Molecular Immunology
This publication has 68 references indexed in Scilit:
- Linking immunity to atherosclerosis: Implications for vascular pharmacology — A tribute to Göran K. HanssonVascular Pharmacology, 2012
- Crosstalk of reactive oxygen species and NF-κB signalingCell Research, 2010
- Increased oxidative stress in atherosclerosis-predisposed regions of the mouse aortaLife Sciences, 2010
- The nuclear factor- B-interleukin-6 signalling pathway mediating vascular inflammationCardiovascular Research, 2010
- Macrophage death and defective inflammation resolution in atherosclerosisNature Reviews Immunology, 2009
- Oxidative risk for atherothrombotic cardiovascular diseaseFree Radical Biology and Medicine, 2009
- Oxidized-LDL induce morphological changes and increase stiffness of endothelial cellsExperimental Cell Research, 2008
- Deficiency of inducible NO synthase reduces advanced but not early atherosclerosis in apolipoprotein E-deficient miceLife Sciences, 2006
- Relative expression software tool (REST(C)) for group-wise comparison and statistical analysis of relative expression results in real-time PCRNucleic Acids Research, 2002
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976